Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babur Salim

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|September 5, 2023
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported surveySakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Rheumatology (Oxford, England)|January 13, 2023
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologistsAgnete Overgaard Donskov, Sarah Louise Mackie, Ellen Margrethe Hauge, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|September 5, 2023
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported surveySakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Rheumatology (Oxford, England)|January 13, 2023
An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologistsAgnete Overgaard Donskov, Sarah Louise Mackie, Ellen Margrethe Hauge, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Pageof 5